Liaoning Port (02880) announces first three quarters results, net profit attributable to shareholders RMB1.378 billion, up 5.96% year on year.
Liaoning Port (02880) announced that for the first three quarters of 2026, the Group recorded operating revenue of RMB8.207 billion, down 2.6% year on year; net profit attributable to shareholders of the listed company was RMB1.378 billion, up 5.96% year on year; basic earnings per share were RMB0.0584442.
Liaoning Port (02880) announced that for the first three quarters of 2026, the Group recorded operating revenue of RMB8.207 billion, down 2.6% year on year; net profit attributable to shareholders of the listed company was RMB1.378 billion, up 5.96% year on year; basic earnings per share were RMB0.0584442.
Related Articles
Victory Giant Technology (02476) plans to make additional investments of no more than US$800 million and US$700 million in its wholly-owned indirect subsidiaries Victory Giant Technology (Thailand) and Victory Giant Technology (Vietnam), respectively.
MICROPORT (00853): Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. reported a net profit attributable to shareholders of RMB449 million for the first three quarters, up 4.55% year on year.
KEYMED BIO-B (02162) intends to purchase shares under the 2022 Restricted Share Unit Plan.
Victory Giant Technology (02476) plans to make additional investments of no more than US$800 million and US$700 million in its wholly-owned indirect subsidiaries Victory Giant Technology (Thailand) and Victory Giant Technology (Vietnam), respectively.
MICROPORT (00853): Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. reported a net profit attributable to shareholders of RMB449 million for the first three quarters, up 4.55% year on year.
KEYMED BIO-B (02162) intends to purchase shares under the 2022 Restricted Share Unit Plan.
